Biotech IPOs: Navigating the New Landscape

Even in a boom, many biotech executives may be unprepared for the risks involved in undertaking an IPO. Noël Brown and Tim Papp, Managing Directors focused on biotechnology in our Global Healthcare Investment Banking and Jason Levitz, Head of Healthcare Equity Capital Markets at RBC Capital Markets discuss the right steps to take, and the pitfalls to avoid, in today’s markets.

Om Podcasten

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.